Pathobiology 2027

Mechanisms of Disease

May 1-4, 2027

Flamingo Las Vegas, Las Vegas, NW

Session 019 – Microbiome-Immune Interactions

8:00-9:45 AM
Sponsored by the Inflammation and Immunopathology Scientific Interest Group
Session Room: TBD

Session Chair

Evan Delgado

Evan Delgado, PhD
Medical University of South Carolina

Session Overview

The microbiome not merely as a collection of organisms, but as an immune organ — a dynamic ecosystem that continuously shapes immune development, homeostasis, tolerance, and inflammatory disease. Once viewed primarily as a local regulator of intestinal immunity, the gut microbiome is now recognized as a key driver of immune responses throughout the body. This session examines how microbial signals influence gut myeloid cell biology and how intestinal barrier dysfunction promotes immune activation along the gut-liver axis, revealing mechanisms by which host-microbiome interactions coordinate health and disease across tissues.

Agenda

  • Co-Chair – Welcome and Introductions

  • Melinda Engevik8:00-8:35 AM
    Bacterial Modulation of Macrophage Activation
    Melinda Engevik, PhD
    Medical University of South Carolinaa

  • Reben Raeman8:35-9:10 AM
    Microbiota, Integrins, and Immune Cells in Liver Injury and Repair
    Reben Raeman, PhD
    University of Pittsburgh School of Medicine

  • Andrei Ivanov9:10-9:45 AM
    Cytoskeletal Mechanisms That Regulate Intestinal Epithelial Cell Interactions with Enteric Pathogens
    Andrei Ivanov, PhD
    Cleveland Clinic Foundation